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Vibrio cholerae is a gram-negative bacterium that has been associated with cholera pandemics since the early
1800s. Whole-cell, killed, and live-attenuated oral cholera vaccines are in use. We and others have focused on
the development of a subunit cholera vaccine that features standardized epitopes from various V. cholerae
macromolecules that are known to induce protective antibody responses. TcpA protein is assembled into
toxin-coregulated pilus (TCP), a type IVb pilus required for V. cholerae colonization, and thus is a strong
candidate for a cholera subunit vaccine. Polypeptides (24 to 26 amino acids) in TcpA that can induce protective
antibody responses have been reported, but further characterization of their amino acid targets relative to
tertiary or quaternary TCP structures has not been done. We report a refinement of the TcpA sequences that
can induce protective antibody. One sequence, TcpA 15 (residues 170 to 183), induces antibodies that bind
linear TcpA in a Western blot as well as weakly bind soluble TcpA in solution. These antibodies bind assembled
pili at high density and provide 80 to 100% protection in the infant mouse protection assay. This is in sharp
contrast to other anti-TcpA peptide sera (TcpA 11, TcpA 13, and TcpA 17) that bind very strongly in Western
blot and solution assays yet do not provide protection or effectively bind TCP, as evidenced by immunoelectron
microscopy. The sequences of TcpA 15 that induce protective antibody were localized on a model of assembled
TCP. These sequences are centered on a site that is predicted to be important for TCP structure.
Vibrio cholerae is a gram-negative bacterium that causes
pandemics of diarrheal disease that can be fatal in untreated
individuals. In some parts of the world, economic, political,
and social conditions are consistent with the potential for fu-
ture cholera epidemics. V. cholerae must colonize the human
intestinal tract following ingestion of contaminated water or
food before virulence genes are expressed (9). The toxin-co-
regulated pilus (TCP) is a homopolymer of a 20.5-kDa TcpA
pilin which is expressed upon infection and is required for
colonization (16). Two biotypes of V. cholerae are associated
with pandemic disease, classical and El Tor. The TcpAs of the
two biotypes are 82% identical, with variability being found in
the C terminus of the protein (11). Other TcpA alleles are
found in non-O1/non-O139 strains, where the sequence of the
TcpA subunit exhibits several additional amino acid substitu-
tions, especially in the area of the last 60 amino acids, which
comprise a disulfide-bound structure that is required for a
functional TCP (1).
Antibodies specific for TcpA are protective (12–15). TCP is
not considered a dominant immunogen because a single-dose,
experimental infection of North American volunteers with V.
cholerae O1 strain O395 induced only a low-titer antibody
response to TcpA (5). However, 50% of a limited number of
sera (three of six) from a highly cholera-endemic area of In-
donesia had TcpA-specific immunoglobulin G (IgG) and IgA
antibodies (5).
Recent data from Calderwood’s group suggest that antibod-
ies to TCP are more prevalent in individuals recovering from
cholera than was previously thought (4). Rabbit anti-TCP an-
tibodies made to purified pilus, when mixed with virulent V.
cholerae (500 50% lethal doses) and administered to infant
mice, provided complete immunity to cholera (13). Protection
was shown to be associated with anti-TCP antibody based on
adsorption experiments. Similar results were obtained with
monoclonal antibodies specific for TcpA as well as with poly-
clonal antibody raised against synthetic peptides correspond-
ing to a region of TcpA adjacent to the domain recognized by
the monoclonal antibody (12, 15). We reported that the pre-
viously identified TcpA peptides TcpA 4 (amino acids 145 to
168), 5 (amino acids 157 to 181), and 6 (amino acids 174 to
199) can be variably immunogenic in mice of different major
histocompatibility complex haplotypes (10, 12). The mecha-
nism of the anti-TcpA antibody’s protective effect is not known
but is likely related to reduced colonization of V. cholerae in
the face of anti-pilin antibody. The means by which coloniza-
tion is affected are perhaps not related to inhibition of bacte-
rial adhesion to host cells but rather to effects on microcolony
formation and thus the association of the bacteria in the intes-
tine (8).
The crystal structure of classical TcpA was recently pub-
lished (3). The TcpA monomer consists of a long N-terminal
alpha-helical tail and a globular domain that results from a
disulfide bond between Cys residues 120 and 186. The N ter-
minus has two alpha-helical (1, 2) stretches that are on one
side of a packed hydrophobic core (-sheets). The / loop
(residues connecting 1 to the  sheet) is predicted to be
involved in pilus structure. A third (3) and fourth (4)  helix
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are on the other side of the hydrophobic core. The last two 
strands, 4 and 3, along with the last two alpha-helices form
the D region, a discrete face containing residues important for
TCP function and residues able to induce protective antibodies
(8, 13–15).
The group that crystallized V. cholerae TcpA generated a
computer TCP model based on energy-minimized structures
that recapitulated physical measurements from cryoelectron
micrographs and x-ray defraction images (3). TCP is about 80
Å in diameter and can be several micrometers long. TCP pili
are left-handed, three-start alpha-helical structures with a
22.5-Å rise and a pitch of 45 Å. Interestingly, the model pre-
dicts that there is an area of interaction between TcpA mono-
mers that might be important for TCP structure. The alpha-
helical N termini of the monomers are predicted to be buried
in the center of the pilus and impart a considerable amount of
binding energy to maintain the structure. There is also exten-
sive contact between the D region and the / loop of neigh-
boring monomers. Amino acids 121 to 186 in the D region and
50 to 77 in the loop are in close proximity, such that L176 and
T125 form hydrogen bounds with Y51 and L76, respectively.
We report here data that refine the location of a B-cell
epitope of TcpA that is able to induce protective antibody
responses. Rabbit serum resulting from immunization with
keyhole limpet hemocyanin-conjugated TcpA 15 peptide (TcpA
amino acids 170 to 183) contained protective antibody that
bound soluble TcpA as well as assembled pilus. TcpA 15 res-
idue D175 was required for Western blot and immunoelectron
reactivity with anti-TcpA 15 serum. TcpA 15 is predicted to be
involved in TcpA subunit interactions required for TCP struc-
ture.
MATERIALS AND METHODS
Animals. Six-month-old New Zealand White female rabbits were used for the
peptide immunization studies under contract with the Pocono Rabbit Farm and
Laboratory (Canadensis, Pa.). Pregnant female CD-1 mice were purchased from
Charles River (Raleigh, N.C.) for use in the infant mouse protection studies. All
mice were housed under standard conditions in the Animal Resources Center
located at the Dartmouth Medical School, Hanover, N.H.
Bacterial stocks and growth conditions. The bacterial stocks used in these
studies are listed in Table 1. Strains were maintained as frozen glycerol stocks
stored at 80°C. Bacteria were streaked onto Luria-Bertani (LB) agar plates and
incubated overnight at 37°C. Bacteria from single colonies were inoculated into
LB medium at pH 6.5 and incubated on a rotary wheel at 30°C for 16 to 18 h to
induce maximal TCP surface expression unless otherwise noted.
TcpA peptides. TcpA peptides 11 through 18, derived from the sequence of the
classical biotype of V. cholerae O1, were prepared and conjugated to keyhole
lymphocyte hemocyanin or bovine serum albumin or left unconjugated by Mac-
romolecular Resources (Colorado State University, Fort Collins, Colo.). The
peptides used for these studies were TcpA 11 (amino acids 141 to 154), AVA
LADLGDFENSA; TcpA 12 (amino acids 148 to 160), GDFENSAAAAETG;
TcpA 13 (amino acids 155 to 169), AAAETGVGVIKSIAP; TcpA 14 (amino
acids 161 to 174), VGVIKSIAPASKNL; TcpA 15 (amino acids 170 to 183),
ASKNLDLTNITHVE; TcpA 16 (amino acids 175 to 186), DLTNITHVEKLC;
TcpA 17 (amino acids 184 to 199), KLCKGTAPFGVAFGNS; and TcpA 18
(amino acids 187 to 199), KGTAPFGVAFGNS. The lyophilized peptides were
resuspended in 5.0% dimethyl sulfoxide–0.25 phosphate-buffered saline (PBS)
to a final concentration of 0.5 mg/ml and stored at 80°C in 1.0-ml aliquots until
used. The relative positions of these peptides within TcpA are shown in Fig. 1.
The locations of the individual TcpA peptides as well as all the TcpA peptides on
the space-filling TcpA monomer model (3) are shown in Fig. 1.
Immunization and serum collection. Synthetic TcpA peptides, conjugated to
keyhole limpet hemocyanin and emulsified in Freund’s adjuvant were injected
into rabbits in decreasing doses employing multiple routes of injection. We
administered 200 g of immunogen for the first three injections in the popliteal
lymph nodes (day 0), subcutaneous and intradermal (day 14), or subcutaneous
inoculation and popliteal lymph nodes (day 28). On day 56, 100 g of immuno-
gen was injected subcutaneously. Rabbits were bled on days 0, 28, 42, 70, and 87,
which represent preimmune, primary, secondary, tertiary, and quaternary sera,
respectively.
Serology. The presence of anti-TcpA-specific antibodies in individual sera was
measured by enzyme-linked immunosorbent assay; 96-well, high-binding, flat-
bottomed microtiter plates (Corning Life Sciences; Acton, Mass.) were coated
with 100 l per well of 0.5 g of TcpA peptides conjugated to bovine serum
albumin in 0.1 M Na2HPO4 binding buffer, pH 9.0, and incubated overnight at
4°C. The plates were washed four times with a Molecular Devices Skan Washer
400 microtiter plate washer with 250 l per well of 1 PBS–0.05% Tween 20
(Fisher Scientific; Pittsburgh, Pa.). Nonspecific binding was blocked with 200 l
per well of buffer consisting of 1 PBS–1.0% bovine serum albumin–0.5%
Tween 20 for 2 h at room temperature. The plates were washed four more times,
after which 50 l of antiserum (serially diluted twofold) was added to each well
and incubated overnight at 4°C. The initial dilution of 1:1,000 was used for all
serum samples. The plates were then brought to room temperature and washed
four times, and 50 l of horseradish peroxidase-labeled goat anti-rabbit IgG
(heavy and light chain specific) (Jackson ImmunoResearch Laboratories, West
Grove, Pa.) detector antibodies (diluted 1:4,000) were added to each well and
incubated at room temperature for 2 h in the dark. The plates were washed six
times and then developed with 100 l per well of 3,3,5,5-tetramethylbenzidine
(TMB) peroxidase substrate (Kirkegaard & Perry Laboratories, Gaithersburg,
Md.) for 30 min at room temperature. The reaction was stopped with an equal
volume of 0.18 M H2SO4. Optical densities (ODs) were read with a Dynex
Technologies MRX microtiter plate reader (Thermo Labsystems, Helsinki, Fin-
land) with Dynex Revelation version 3.04 software at  	 450 nm with 630 nm
as the reference wavelength.
Immunoelectron microscopy. We centrifuged 250 l of an overnight culture of
V. cholerae O1 and resuspended it in 1 ml of LB at pH 6.5. A humidified chamber
was prepared by lining the bottom of a glass petri dish with moistened filter
paper, and 4% Formvar-coated, 300-mesh nickel support grids were placed in the
dish on top of the parafilm. Each grid was covered with a 15-l drop of bacterial
suspension and sealed in the petri dish with parafilm. The grids were incubated
at 30°C for 3 h in a dry-heat incubator. Excess medium was wicked from the grids
by carefully touching their edges to Whatman filter paper. For all subsequent
manipulations, a 10-in.-square sheet of parafilm was fixed to a flat surface on the
bench and the grids were transferred from the petri dish to the parafilm. The
grids were covered with an inverted glass Pyrex baking dish to prevent evapora-
tion during incubation periods. Grids were then fixed for 1 h at room tempera-
ture by placing a 15-l drop of fixative buffer (2.0% paraformaldehyde, 0.5%
glutaraldehyde, 50 mM sodium cacodylate, pH 7.4) over each grid. Following
incubation, the grids were drained of excess fixative and washed four times in
Tris-buffered saline with 0.05% Tween-20 (TBST).
Nonspecific antibody binding was blocked with TBST with 1% bovine serum
albumin for 30 min at room temperature. Anti-TcpA serum was diluted 1:500 in
TBST–1% bovine serum albumin and allowed to incubate on the grids for 1 h at
room temperature. The grids were washed four times in TBST before adding
10-nm colloidal gold-conjugated goat anti-rabbit IgG detector antibody (ICN
Biomedicals, Irvine, Calif.) diluted 1:100 in TBST and incubated for 30 min.
Unbound antibody was removed with four more washes, and then the grids were
negatively stained for 2 min with 0.5% phosphotungstic acid, pH 6.5 (Electron
TABLE 1. Strains used for Western blot, immunoprecipitation,
immunoelectron microscopy, and infant mouse protection assays
Strain Species TCP
O395 V. cholerae O1 classical Wild-type TCP
RT4031 V. cholerae O1 classical TCP negative
RT4018 V. cholerae O1 classical P1693A
RT4056 V. cholerae O1 classical K1723A
RT4054 V. cholerae O1 classical D1753A
RT4506 V. cholerae O1 classical T1803A
RT4058 V. cholerae O1 classical H1813A
RT4060 V. cholerae O1 classical E1833A
RT4055 V. cholerae O1 classical K1843A
RT4062 V. cholerae O1 classical K1873A
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Microscopy Sciences, Hatfield, Pa.). The grids were then removed to a storage
box and placed in a desiccating environment at room temperature until viewed.
The grids were viewed with a Jeol, JEM-1010 40 kV to 100 kV transmission
electron microscope housed at the Julius A. Rippel Electron Microscopy Facility
(Dartmouth College, Hanover, N.H.). All images were photographed at 25,000
magnification. The resulting micrographs were scanned into Adobe Photoshop
7.0 with a UMax PowerLook (Dallas, Tex.) 1120 overhead transmission flatbed
scanner at 1,200 dots per inch and then converted into jpg format.
Infant mouse challenge. The suckling mouse challenge model for cholera was
used for assessing the protective quality of anti-TcpA-specific antibodies in vivo
(2, 13). Cultures of V. cholerae (classical Ogawa strain O395) were grown for 16 h
under toxin-coregulated pilus-expressing conditions (LB at pH 6.5 and 30°C); 25
l of bacterial suspension, diluted to 4.4 50% lethal doses, was combined with 25
l of either preimmune serum (negative control) or tertiary anti-TcpA-specific
serum immediately before intragastric administration to 4- to 5-day-old CD-1
mice. Challenged mice were kept at 30°C and monitored every 4 h starting 24 h
postchallenge until the termination of the experiment at 48 h. GraphPad Prism
4.0 was used to generate survival curves. The assay was repeated six times for the
TcpA 15 tertiary bleed sample with a range of concentrations (4.4 to 70.0 50%
lethal doses) of challenge bacteria.
SDS-PAGE and Western blot. Bacteria from overnight cultures were trans-
ferred to microcentrifuge tubes and centrifuged at 13,000  g for 1 min. The
resulting pellet was resuspended in 0.20 volume of sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis (PAGE) sample buffer containing 2-mercap-
toethanol. Each sample was boiled for 10 min and then centrifuged for 10 min at
13,000  g. Samples were loaded onto a 10% polyacrylamide gel and electro-
phoresed for 1 h at 150 V. The gel was allowed to come to equilibrium in
Western blot transfer buffer for 10 min, and then proteins were electrophoreti-
cally transferred to a nitrocellulose membrane (Schleicher & Schuell Bioscience
Inc., Keene, N.H.) with a Bio-Rad semidry transfer system at 23 V for 35 min.
The nitrocellulose membrane was blocked for 2 h at room temperature or
overnight at 4°C with 5% nonfat dry-milk in PBS–0.05% Tween 20 (PBST).
Antiserum from rabbits injected with TcpA peptides was diluted 1:10,000 to
1:50,000 in blocking buffer, and the nitrocellulose was incubated for 2 h at room
temperature and then washed six times for five min in PBST. Goat anti-rabbit
horseradish peroxidase IgG detector antibody (Jackson ImmunoResearch Lab-
oratories) was diluted 1:8,000 in PBST and incubated with the nitrocellulose for
30 min at room temperature. The nitrocellulose was then washed six times for 5
min. For Western blotting with the TcpA-specific monoclonal antibody, purified
169.1 was diluted 1:500 and incubated for 30 min before being washed as above
and the addition of goat anti-mouse IgG2b horseradish peroxidase-conjugated
antibody (1:8,000) followed by subsequent washes. Enhanced chemiluminescent
reagent (Amersham Biosciences, Piscataway, N.J.) was applied to the nitrocel-
lulose, and the membrane was exposed to Kodak BioMax film for various periods
of time (15 s up to 1 h). Developed film was scanned into a computer file with a
Umax PowerLook 1120 overhead transmission flatbed scanner and then con-
verted into jpg format with Adobe Photoshop 7.0.
TcpA purification. Overnight cultures of Escherichia coli Origami DE cells
containing the plasmid pET15b-cl-TcpA clone (expressing the polyhistidine-
tagged wild-type TCP protein) were cultured in a shaker incubator at 37°C, 250
rpm (3); 10 ml of the overnight culture was inoculated into 1 liter of LB broth
and grown to an OD600 of 0.6. Isopropyl--D-thiogalactoside was added to a final
concentration of 0.01 M, and the cultures were grown overnight at 30°C, 250 rpm.
Cells were centrifuged in a Sorvall GSA rotor at 6,000 rpm (5,858  g) for 15 min
at 4°C. The pellet was resuspended in 100 ml of cold equilibration-wash buffer
(50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, 1 mM phenylmethylsul-
fonyl fluoride, pH 7.0), sonicated, and centrifuged in a Sorvall SS-34 rotor at
14,000 rpm (23,420  g) for 20 min at 4°C. The supernatant was passed over a
FIG. 1. Classical, toxin-coregulated pilus protein A (TcpA) peptides that were synthesized for this study and their locations on the classical
TcpA monomer. TcpA peptides 11 to 18 were synthesized with a C residue at the C termini and conjugated by a disulfide bond to keyhole limpet
hemocyanin (KLH) for immunization of rabbits as described in Materials and Methods. Colored peptides are correlated with the colored amino
acids in the space-filling model of TcpA and define the locations of the primary amino acid sequences of the TcpA peptides on the folded TcpA
monomer. RasMol version 2.7.2.1 molecular visualization software was used to display and manipulate the Brookhaven Protein Data Bank
(available through the National Center for Biotechnology Information [http://www.ncbi.nlm.nih.gov]) TcpA file 1OQV (3).
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Talon Metal affinity resin column (BD Clontech, Palo Alto, Calif.), and bound
protein was eluted with 50 mM NaH2PO4–300 mM NaCl–250 mM imidazole, pH
7.0. Fractions containing TcpA were pooled and concentrated with a Sephacryl
S-100HR column (Amersham Biosciences, Piscataway, N.J.).
Immunoprecipitation of biotinylated TcpA. We biotinylated 1 mg of soluble
polyhistidine-tagged classical TcpA with Pierce EZ-Link sulfo-NHS-LC-biotin,
following the manufacturer’s protocol (Pierce Biotechnology Inc., Rockford,
Ill.); 5 l of rabbit TcpA polypeptide tertiary antiserum or preimmune antiserum
was incubated with approximately 2 g of biotinylated soluble TcpA overnight at
4°C; 20 l of streptavidin-Sepharose (Amersham Biosciences, Piscataway, N.J.)
was added to each sample and incubated at room temperature for 2 h. Each
sample was washed three times with PBS–1% nonfat dry milk. The pellet was
resuspended in 20 l of SDS-PAGE sample buffer containing 2-mercaptoetha-
nol. A 1:20 dilution in sample buffer with 2-mercaptoethanol was made, boiled
for 10 min, and centrifuged for 10 min, and 10 l of the supernatant was loaded
onto a 10% polyacrylamide gel. The proteins were transferred to a nitrocellulose
membrane and blocked with PBST containing 3% nonfat dry milk for 2 h at
room temperature. The membrane was then incubated for 2 h at room temper-
ature with goat anti-rabbit IgG-horseradish peroxidase antibody diluted 1:5,000
in blocking buffer. Unbound antibody was removed by washing before the de-
tection of bound antibody.
Immunoprecipitation of unbiotinylated TcpA. HIS-Select HC nickel affinity
beads (Sigma, St. Louis, Mo.) were washed with 2 volumes of deionized water
and then 1 volume of wash buffer (50 mM sodium phosphate, pH 8.0, 0.3 M
sodium chloride) to remove ethanol; 15 l of washed beads was incubated
overnight at 4°C with 100 g of soluble classical TcpA lysate. The samples were
washed five times with 1 ml of wash buffer, resuspended in 25 l of wash buffer,
and 10 l of TcpA 14-mer tertiary or preimmune antiserum (diluted 1:25 in wash
buffer) was added and incubated overnight at 4°C. The samples were washed
three times with 1 ml of wash buffer, resuspended in 20 l of 1x SDS-PAGE
sample buffer with 2-mercaptoethanol, boiled for 10 min, and centrifuged 10 min,
and the supernatant was loaded onto a 10% polyacrylamide gel. Proteins were
transferred to nitrocellulose and blocked 2 h with PBST containing 5% nonfat
dry milk-horseradish peroxidase-labeled detector antibody diluted 1:5,000 in
PBST and incubated for 2 h, then the nitrocellulose was washed and the ECL
reagent was added, and the blots were exposed to film.
TcpA and TCP structure modeling. RasMol version 2.7.2.1 molecular visual-
ization software (Herbert J. Bernstein, Bernstein and Sons, P.O. Box 177, Bell-
port, N.Y.) was used to manipulate the files 1OQV (TcpA) and 1OR9 (TCP
model) which were downloaded from the Protein Data Base (available through
the National Center for Biotechnology Information [http://www.ncbi.nlm.nih
.gov]).
RESULTS
Immunogenicity of TcpA peptides as determined by enzyme-
linked immunosorbent assay. Previous work showed that
TcpA is required for colonization of V. cholerae in humans and
mice (5, 16). The nucleotide and amino acid sequences for
both biotypes of TcpA have been reported previously (11).
Peptides from the carboxyl end (amino acids 144 to 199) of
classical TcpA, TcpA 4 (amino acids 145 to 168), TcpA 5
(amino acids 157 to 181), and TcpA 6 (amino acids 174 to 199)
were shown to induce protective antibody responses in rabbits
(12–15). Since the antibody combining site can accommodate
some 7 to 10 amino acids depending on the orientation and
conformation of the B-cell epitope, the precise localization of
potential protective epitopes within the larger 24 to 26 TcpA
polypeptides was unknown.
We made a series of smaller overlapping TcpA polypeptides
of between 12 and 16 amino acids that spanned the region
covered by the larger TcpA 4, 5, and 6 peptides. These smaller
TcpA peptides were coupled to keyhole limpet hemocyanin
and assessed for their immunogenicity in rabbits (Fig. 1). The
N termini of the sequential peptides (TcpA 11 to 18) was
moved, depending on the peptide, progressively 3 to 10 amino
acids towards the carboxyl end to produce immunogens with
variable N-terminal ends that, given the linkage to keyhole
limpet hemocyanin, were the most likely structures available to
induce B-cell responses. The locations of the individual TcpA
peptides (colored space filling residues) are shown on the
TcpA crystal structure that was recently reported by Craig and
colleagues (3) (Fig. 1). If the complete set of TcpA peptides we
generated are highlighted on the TcpA crystal structure, it can
be seen that the surface area of the globular domain of TcpA
that is potentially immunogenic can be extensively examined
with these peptides.
Rabbits were universally able to make anti-TcpA polypep-
tide antibodies, the titers of which increased with time and
booster immunizations. The endpoint titers for all antipeptide
sera at the tertiary bleed (day 70) were between 1:10,000 and
1:1,000,000 (Fig. 2). Tertiary bleed sera were used as the stan-
dard sera for subsequent analyses. As a group, the even-num-
bered peptides were less immunogenic than the odd-numbered
peptides, with the average endpoint titers being 2.0  106 for
the odd-numbered antipeptide sera and 0.4  106 for the
even-numbered peptide sera.
Recognition of TcpA sequence in the context of full-length
linear TcpA. As all TcpA peptides were immunogenic as as-
sessed by enzyme-linked immunosorbent assay analysis, we
performed Western blotting analyses to assess the capacity of
the antipeptide sera to bind TcpA sequences in the context of
full-length TcpA. Negative controls included prebleed sera
from all rabbits and assessment of tertiary sera against bacteria
deleted for tcpA (Fig. 3). The capacity of the individual rabbit
sera to recognize TcpA in Western blotting with the immuniz-
ing sequences now being contextually associated with other
TcpA sequences revealed differences in the ability of the an-
tisera to recognize linear TcpA (Fig. 3). Several anti-TcpA
peptide antibodies, TcpA 11, TcpA 14, and TcpA 18, were
highly reactive in Western blotting, but others were less so
(TcpA 13, TcpA 15, and TcpA 17) or negative (TcpA 12 and
TcpA 16). The dilutions of the various antisera, while compa-
rable, were not identical. It is possible that the difference in the
signals was related to a particular serum’s antibody concentra-
tion or the affinity of those antibodies.
Alternatively, the diminution in signal could be due to the
availability of the epitope. The degree of reactivity in Western
blotting did not correlated with the enzyme-linked immunosor-
bent assay titers of the anti-TcpA peptide sera. Anti-TcpA 17
and anti-TcpA 18 had similar enzyme-linked immunosorbent
assay titers but reacted differently in Western blotting against
full-length TcpA.
Assessment of the ability of anti-TcpA polypeptide sera to
recognize soluble, recombinant TcpA. Classical TcpA has re-
cently been crystallized, and the structure was solved at the
level of 1.3 Å (3). The form of classical TcpA that was used for
the crystal structure was genetically substituted at the first 28
amino acids with codons for 21 N-terminal histidines and
grown in the E. coli stain Origami to enhance formation of the
TcpA disulfide bond. We wanted to determine if the various
anti-TcpA polypeptide sera could react with folded TcpA sub-
units. In order to maximize the signal from the pulldown assay,
biotinylated TcpA derived from nickel column-purified TcpA
was reacted with rabbit antiserum, and the complex was pulled
down by streptavidin-Sepharose and probed for bound rabbit
antibody (Fig. 4, top panel, 50 kDa, heavy chain of rabbit IgG).
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Additionally, to confirm the results and to avoid the potential
confounding influence of biotinylation on epitope availability,
we used nickel-Sepharose beads to pull down antigen-antibody
complexes (Fig. 4, bottom panel).
The enzyme-linked immunosorbent assay titers of the vari-
ous anti-TcpA sera were not predicative of the ability of the
antisera to interact with soluble TcpA. Both low-titer (anti-
TcpA 14) and high-titer (anti-TcpA 18) sera failed to interact
strongly with soluble TcpA. Similarly, the degree of binding in
Western blotting was not predicative of binding soluble TcpA.
The most efficient sera at binding soluble TcpA, anti-TcpA 13
and anti-TcpA 17, were in the second tier for Western blotting
binding signals. The lack of interaction of some sera in the
pulldown assay could be due to the fact that the linear im-
munogen sequence is not exposed on the TcpA protein or that
the labeling of TcpA with biotin affected the B-cell epitope. All
of the TcpA polypeptides (except TcpA 11 and TcpA 12)
contain a Lys, and thus biotin bound to Lys could be com-
pletely or partially obscuring the B-cell epitope. We repeated
the assay with unbiotinylated TcpA. The IgG-TcpA complex
was isolated with nickel-Sepharose beads and then probed with
anti-rabbit IgG-horseradish peroxidase. The degree of associ-
ation of both forms of TcpA with TcpA-specific rabbit IgG was
compared by quantitating the pixel intensity of the Western
blotting results and then grouping the responses in rank order
(data not shown). The results were essentially the same for
both forms of TcpA.
Efficacy of anti-TcpA polypeptide rabbit sera to protect in-
fant mice from challenge with virulent V. cholerae. There are
two means to test the efficacy of potential cholera vaccine
formulations. The ultimate test is in human volunteers, but the
more proximal means to assess vaccine efficacy is the infant
mouse protection assay. Antiserum is combined with a known
dose of virulent V. cholerae and introduced via gavage into the
gut of 4- to 5-day-old infant CD-1 mice. We used the infant
mouse protection assay to assess selected prebleed rabbit sera
and all of the anti-TcpA polypeptide antisera for their ability to
protect against lethal oral challenge with 4 to 70 50% lethal
doses of virulent V. cholerae (Fig. 5). The only antiserum that
was protective (80%) was anti-TcpA 15. Importantly, prebleed
FIG. 2. Rabbit anti-TcpA 11 to 18 sera specific for sequences from classical V. cholerae O1 toxin-coregulated pilus protein A (TcpA). Rabbits
were immunized with synthetic TcpA polypeptides coupled to keyhole limpet hemocyanin (KLH). The immunization protocol employed multiple
routes and multiple injections. Serum samples were collected on days 0 (preimmune), 28 (primary), 42 (secondary), 70 (tertiary), and 87
(quaternary). Primary rabbit serum was serially diluted in twofold increments, starting at 1:1,000. Enzyme-linked immunosorbent assay results are
reported as optical densities measured at 450 nm.
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sera from the rabbit immunized with TcpA 15 were completely
ineffective at protecting infant mice from oral challenge (Fig.
5C). The only other peptide antiserum that appeared to offer
some protection in the infant mouse model was anti-TcpA 11.
This serum did not offer long-term protection compared to the
TcpA 15 antiserum, but the immunized mice clearly took
longer to die than the mice from groups challenged with viru-
lent V. cholerae combined with the other anti-TcpA peptide
sera. Multiple protection experiments revealed that the anti-
TcpA 15 serum could provide between 70 and 100% protection
against 4.4 to 70 50% lethal doses.
Efficacy of anti-TcpA polypeptide rabbit sera to bind assem-
bled TcpA subunits of virulent V. cholerae. The ultimate bio-
chemical assessment of anti-TcpA peptide sera is to determine
the ability of antisera generated to isolated linear amino acid
sequences to bind assembled TCP. The association of TcpA
FIG. 3. Western blot (WB) analysis of toxin-coregulated pilus protein A (TcpA). Whole-cell lysates of classical V. cholerae O395 (wild-type [wt]
TcpA and TcpA deleted [
tcpA]) were electrophoresed through 10% polyacrylamide gel and detected by anti-classical TcpA 11 to 18 peptide
tertiary sera. The corresponding preimmune (PI) serum was used as the negative control. Some anti-TcpA peptide sera were more reactive in
Western blotting (TcpA 11, TcpA 14, and TcpA 18), while others were less so (TcpA 13, TcpA 15, and TcpA 17), and two were negative (TcpA
12 and TcpA 16).
FIG. 4. Soluble toxin-coregulated pilus protein A (TcpA) can interact with some anti-TcpA peptide antisera. (Top) A pulldown analysis which
assessed the ability of anti-classical TcpA peptide serum to interact with TcpA monomers was performed. Purified, biotin-labeled TcpA was
incubated overnight at 4°C with anti-TcpA peptide prebleed or tertiary serum, and then 20 l of streptavidin-Sepharose (in PBS–1% nonfat milk) was
added for 2 h at room temperature, followed by washing, electrophoresis, and subsequent Western blot analysis with horseradish peroxidase-labeled goat
anti-rabbit IgG, antibody. (Bottom) Purified TcpA lysate was incubated overnight at 4°C with His-Select nickel affinity beads and washed, and anti-TcpA
peptide preimmune (PI) or tertiary serum was added and incubated overnight at 4°C. Samples were washed before pellets were resuspended and analyzed
in a Western blot as described for the top panel. rIg, rabbit IgG control.
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monomers and then the association of three alpha-helical
strands that is predicted from the TCP model (3) suggests that
certain TcpA residues will be buried in monomer-monomer
interaction or in individual fiber interactions.
We used immunoelectron microscopy to determine the abil-
ity of anti-TcpA peptide sera to bind assembled TcpA (Fig. 6).
The electron micrographs show that the negative control se-
rum (preimmune TcpA 15) does not interact with assembled
TCP. Similarly, hyperimmunization of a rabbit does not pro-
duce serum that nonspecifically binds TCP due to high levels of
IgG (TcpA 12 panel). As would be consistent with its protec-
tive capacity, the positive control serum (anti-TcpA 6) sera
bound TCP with high density. Representative micrographs of
anti-TcpA sera that bound TCP with high or moderate to low
density are shown. Of the various TcpA 11 to 18 antisera, only
anti-TcpA 15 serum, which was protective, bound TCP with
high density. The other anti-TcpA peptide sera bound less
effectively than anti-TcpA 15 serum. Analysis of multiple im-
ages from independent grids suggests that the other sera bind
either moderately (TcpA 11 and TcpA 13) or poorly (TcpA 14,
TcpA 17, and TcpA 18) to TCP (data not shown).
Assessment of TcpA amino acids required for TcpA 15 an-
tiserum reactivity. Previously, Kirn and colleagues reported
the effect of engineered missense mutations within tcpA on the
structure and functional activity of TCP (8). They found that
six residues in classical TcpA within a 16-amino-acid run (K172
to K187) could be mutated to Ala and not affect expression of
TCP but could affect TCP functions: autoagglutination capac-
ity, colonization efficiency, phage transduction efficiency, or
serum resistance. These residues (K172, D175, H181, E183,
K184, and K187) were termed interactive residues. TcpA 15
peptide contains four of the six interactive residues.
We examined pilin containing altered interactive residues by
Western blotting analysis to determine if any of the amino acid
changes affected the ability of anti-TcpA 15 serum to bind
linear TcpA (Fig. 7A). Pilins with substitution of Ala residues
in TcpA residues upstream or downstream of amino acids 170
to 183 were used as controls. The anti-TcpA monoclonal an-
tibody 169.1 served as a positive control (15). This monoclonal
antibody reacts with TcpA 5 (157 to 181), binds TCP with high
density, and provides protection in the infant mouse assay (15;
unpublished observations). Anti-TcpA 15 serum was able to
react with TcpA pilin that had amino acid changes within the
TcpA 15 sequence (170 to 183) and outside of the TcpA 15
sequence. The exception was that anti-TcpA 15 serum was
unable to bind TcpA with an Ala substitution at 175, which is
an aspartate in classical TcpA. The alteration (diminution) of
binding was also seen when monoclonal antibody 169.1 was
used to probe the D175A derivative. We used immunoelectron
microscopy to assess the ability of anti-TcpA15 serum to bind
the D175A mutant within TcpA that was folded and assembled
into TCP. The Ala substitution of D175 severely reduced anti-
TcpA 15 binding to assembled, morphologically normal TCP
(Fig. 7B). The isotype-matched monoclonal antibody control
did not bind to the D175A pilus.
DISCUSSION
Colonization of bacteria at specific host sites is often a rate-
limiting step in the pathogenesis of the particular pathogen. In
cholera, for disease to occur, a large inoculum of V. cholerae is
required for a sufficient number of live bacteria to transit the
acidic pH of the stomach and the bile-rich regions of the
intestine. Responding to environmental cues, surviving bacte-
ria upregulate a set of genes required for colonization (9). One
of these genes is tcpA, which is contained on the vibrio patho-
genicity island (6). TcpA and a number of coregulated proteins
(TcpB, -C, -D, -E, -F, -Q, -R, -S, and -T) are required for
assembly, export, and function of TCP, a type IVb pilus (3, 7,
16). These pili are thought to be important for “self-adher-
ence” so that V. cholerae can form microcolonies in the area of
crypt epithelium (8). An expressed TcpA product and assem-
bled pilus is not sufficient for colonization, as 
tcpF strains
produce morphologically normal TCP but do not colonize in-
fant mice (7).
The mechanism by which anti-TcpA or anti-TCP antibodies
are protective is not known. Our results presented here and the
recently published model of the type IVb pilus of V. cholerae
suggest a potential protective mechanism for anti-TCP anti-
bodies, that is, the ability of TcpA-specific antibodies to bind
pilus in a specific area associated with the quaternary structure
FIG. 5. Survival of infant mice following oral challenge with virulent classical V. cholerae O1 bacteria treated with anti-TcpA (toxin-coregulated
pilus protein A) peptide serum. Groups of 10 4- to 5-day-old CD-1 mice were orally gavaged with 4.4  106 CFU of classical V. cholerae O1 Ogawa
bacteria (representing 4.4 50% lethal doses) which was mixed with tertiary antisera (A and B) or preimmune antisera (C); some pups were not
infected (C). Mice were kept at 30°C and monitored for death every 4 h starting 24 h after oral challenge. The protection data for anti-TcpA 15
serum are representative of seven independent challenge assays. In six independent experiments, protective efficacy ranged between 70 and 100%
(mean, 91.4%) for anti-TcpA 15 serum.
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generated by the assembly of TcpA monomers. The residues in
TcpA 15, amino acids 170 to 183, are contained in TcpA 5
(amino acids 157 to 181) and TcpA 6 (amino acids 174 to 199).
Both TcpA 5 and TcpA 6 induced protective antibody re-
sponses in rabbits (12, 14). If the B-cell epitope(s) in TcpA 5
and TcpA 6 is the same as those contained within TcpA 15, this
would localize the protective B-cell epitope to amino acids 174
to 181, the common sequence between TcpA 5, TcpA 6, and
TcpA 15. Because of the relative position (very close to the N
terminus) in TcpA 6 of D175, a critical amino acid recognized
by anti-TcpA 15 serum, it is more likely that the sequence from
174 to 181 represents an area that is sensitive to antibody
binding that disrupts TCP function rather than the antibodies
being specific for exactly the same B-cell epitope.
If the sequence of TcpA15 is examined for conserved resi-
dues between V. cholerae biotypes and isolates that can colo-
nize infant mice (1, 11) an interesting picture emerges. TcpA
15 contains four (K172, D175, H181, and E183) of the six
interactive amino acids (K172, D175, H181, E183, K184, and
K187) previously identified as being important for TCP func-
FIG. 6. Transmission immunoelectron microscopic analysis of anti-TcpA (toxin-coregulated pilus protein A)-specific antibodies binding to
classical V. cholerae O1 TCP. Bacteria were incubated with various TcpA peptide-specific sera on 4% Formvar-coated, 300-mesh nickel support
grids, washed to remove unbound antibody, and fixed in 2.0% paraformaldehyde–0.5% glutaraldehyde buffer. Bound antibody was detected with
10.0-nm gold particle-conjugated goat anti-rabbit IgG. Grids were negatively stained with 0.5% phosphotungstic acid (pH 6.5) and viewed with a
transmission electron microscope at 25,000 magnification (inset). The inset shows the relationship of TCP and bacteria. The pilus shown in the
individual panels corresponds to a magnified view of the pilus in the inset.
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tion (Fig. 8A). Substitution of Ala for the various wild-type
interactive amino acids selectively alters some functions of
TCP. These functions include autoagglutination capacity (K172,
K184, and K187) efficient host colonization (D175, H181,
E183, K184, and K187), serum resistance (K172, K184, and
K187), and phage transduction efficiency (8). In particular,
substitution of Ala at residue D175 still allows V. cholerae to
maintain its autoagglutination phenotype, but this strain has a
100-fold defect in its colonization capacity. Aspartate 175 is
important for anti-15 TcpA binding to SDS-linearized TcpA in
a Western blotting assay and for binding of assembled pilus.
TcpA 15 is nested within several of the TcpA peptides (TcpA
13, TcpA 14, and TcpA 17) that were not able to induce
protective serologic responses (Fig. 8B).
TcpA 15 can be divided into two parts based on the con-
served nature of the residues (Fig. 8A). Hydrophilic residues
K172, E175, and E183 are on and adjacent to the 4 helix in
the D region (3). Histidine 181, which is partially buried, is a
conserved residue that if changed to an Ala produces morpho-
logically normal pilus but results in a state of either excess
TcpA production or destabilized TCP, as increased amounts of
TcpA monomers are found in spent culture supernatants (8).
Two of the interacting residues, 172 (A, K, T, or V) and 175
(D, K, or N) are allowed to vary between biotypes yet still
maintain a functional TcpA that can form pili that mediate
wild-type levels of colonization (1, 11). Residues N173, L174,
L176, I179, H181, V182, and E183 are conserved amino acids
between the classical, El Tor biotypes, and other colonization-
competent vibrios. Residues in the D region of the TcpA
subunit are involved in subunit interaction. In particular, L176,
which does not vary between classical and El Tor TcpA, is
predicted to form a hydrogen bond with Y51 in the / loop of
FIG. 7. Western blot and immunoelectron microscopic analyses of V. cholerae expressing wild-type TcpA (toxin-coregulated pilus protein A),
TcpA-deleted strains, and various pilin mutant strains that express TcpA with an Ala substitution in a specific interactive residue (8) (A) Anti-TcpA
15 tertiary serum (upper panel) diluted 1:12,500 was used to probe the membranes and compared to mouse monoclonal antibody 169.1 (lower
panel), which is specific for TcpA 5 and known to provide protection in the infant mouse assay (15). (B) The effect of the D175A alteration on
binding of anti-TcpA 15 serum to TCP was tested. The D175A change resulted in the complete loss of binding of TcpA 15 serum. An isotype
control monoclonal antibody was negative for binding to TCP.
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an adjacent classical TcpA subunit (Fig. 8C) (3). The mainte-
nance of specific residues among colonization-competent V.
cholerae suggests the involvement of residues for a necessary
function which could be targets for protective antibodies. How-
ever, based on the TCP model, many of the conserved residues
appear to be partially buried in the TCP fiber model, while
other TcpA 15 residues, specifically K172, D175, and E183,
project away from the pilus (Fig. 8D).
FIG. 8. Computer-generated space-filling model of TcpA (toxin-coregulated pilus protein A) 15 and its location on TCP. The RasMol version
2.7.2.1 software was used to display and manipulate the Brookhaven Protein Data Bank files 1OQV (TcpA, panel A) and 1OR9 (TCP model,
panels B to D) (3). (A) TcpA 15 comprises amino acids 170 to 183. TcpA 15 contains four (K172, D175, H181, and E183) of the six interactive
amino acids (K172, D175, H181, E183, K184, and K187) previously identified as being important for TCP function. The TcpA residues (N173,
L174, L176 [cyan], I179, H181, and V182) that do not vary between biotypes or colonizing-competent environmental isolates of V. cholerae are
colored red. Eight of the 14 residues that comprised TcpA 15, A170, S171, K172, D175 (yellow amino acid), T177, N178, T180, and E183 (orange
amino acids), vary between naturally occurring, functional TcpA alleles. Residue L176 is involved with Y51 in a hydrogen bond interaction. (B) The
primary amino acid sequence of TcpA peptides (11 to 18) used to immunize rabbits are shown in the one-letter code and color coded for the
individual TcpA peptides which are displayed on the TCP fiber model. Lysine residues are underlined. A TCP fiber model has been proposed (3).
TcpA 15 is red and is partially exposed, nested between other TcpA peptides, all of which are displayed in a repeating pattern on the surface of
the TCP fiber. (C) Residues 30 to 199 of selected chains (C, B, E, H, G. J, M, and L) of the TCP model were restricted (displayed without N
termini) with the RasMol program and displayed. This TCP representation shows that D175 (yellow) is exposed and available for antibody binding.
There is a recessed “pocket,” 30 by 20 Å, where TcpA 15 is located within the quaternary structure of TCP. Orange residues represent amino acids
that can vary in TcpA 15, while red residues are conserved. Leucine 176 is cyan, and Y51 is blue. Residues 50 to 70 (pink, except 51) represent
the sequence area in the / loop that bind the D region on an adjacent monomer. (D) Enlarged area showing the face of TcpA on adjacent
monomers that are proposed to interact. The color scheme for the amino acids is as above.
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While it is clear the anti-TcpA 15 serum is protective, it is
not evident why antisera to the TcpA residues defined by TcpA
11, TcpA 13, TcpA 14, and TcpA 17 are not. If the protective
effect was from generalized “blocking” of an area related to
function provided by amino acids 170 to 183, then the footprint
(700 to 1,200 Å2) of anti-TcpA 11, TcpA 13, TcpA 14, and
TcpA 17 Fabs (fraction antigen binding; heavy and light
chains) might be expected to occlude the sequence defined by
TcpA 15. The area on the TCP model defined by the TcpA
peptides that surround TcpA 15 is on the order of 10 to 20Å
(Fig. 8D). Thus, either these nonprotective antibodies do not
have enough affinity or are not in high enough concentration or
the epitopes they bind are not as easily accessible as are the
sequences bound by TcpA 15. This concept is supported in part
by the data presented here: anti-TcpA 11, anti-TcpA 13, and
anti-TcpA 17 serum bind soluble TcpA very well but not as-
sembled pilus. Based on the model of TCP (3) and the pro-
tective efficacy of anti-TcpA 15 serum, TcpA 15 is positioned to
have a major impact on TCP structure (Fig. 8D). The issue that
needs to be resolved is how antibody binding in this region
provides protection.
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